Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-24

FDA Approved: PALYNZIQ — Original Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approved PALYNZIQ (pegvaliase-pqpz) from BioMarin Pharmaceutical for the treatment of adults with phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

ORIG AP for PALYNZIQ (PEGVALIASE-PQPZ)